Overview

SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness of diet management with a losartan based titration regimen versus losartan based titration regimen alone on blood pressure reduction in hypertensive patients.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Calcium
Calcium Channel Blockers
Hydrochlorothiazide
Losartan